DIASORIN SPA (DIA.MI) Stock Price, Quote, News and Overview
BIT:DIA - Euronext Milan - IT0003492391 - Common Stock - Currency: EUR
DIA.MI Quote, Performance and Key Statistics
BIT:DIA (3/7/2025, 7:00:00 PM)
96.42
+1.02 (+1.07%)
The current stock price of DIA.MI is 96.42 EUR. In the past month the price decreased by -3.92%. In the past year, price decreased by -0.6%.
DIA.MI Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 28.81 | 214.85B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 69.31 | 166.86B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 39.18 | 133.56B | ||
| 1BSX.MI | BOSTON SCIENTIFIC CORP | 39.52 | 133.38B | ||
| 1MDT.MI | MEDTRONIC PLC | 17.48 | 113.17B | ||
| 2M6.DE | MEDTRONIC PLC | 17.56 | 110.81B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 25.27 | 60.49B | ||
| BOX.DE | BECTON DICKINSON AND CO | 16.4 | 60.33B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 23.49 | 59.08B | ||
| 1EW.MI | EDWARDS LIFESCIENCES CORP | 26.07 | 39.21B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 26.65 | 37.76B | ||
| DC4.DE | DEXCOM INC | 48.5 | 28.81B |
Related stock screener links
About DIA.MI
Company Profile
DiaSorin SpA engages in developing, producing and marketing reagent kits for laboratory diagnostics. The company is headquartered in Saluggia, Vercelli and currently employs 3,233 full-time employees. The company went IPO on 2007-07-19. The firm specializes in provision of developing, producing and commercializing reagent kits for the in vitro diagnostics. The firm develops and manufactures reagents for in vitro diagnostics and produces products for the fields of infectious disease, hepatitis, endocrinology, bone & mineral metabolism, cancer, brain injury, cardiac, therapeutic drug monitoring and autoimmunity. The Company’s business activities are divided into two markets. The Immunodiagnostics market develops, produces and markets immunoreagent kits, which are based on three techniques: Chemiluminescence (CLIA), Colorimetry (ELISA) and Radioimmunometry (RIA). The Molecular Diagnostics market supplies end laboratories with an automated result to perform the three steps for the final diagnostic result, including nucleic acids extraction, amplification and diagnosis. The company operates through ELISA immunodiagnostic business portfolio.
Company Info
DIASORIN SPA
Via Crescentino Snc
Saluggia VERCELLI IT
Employees: 3186
Company Website: https://www.diasorin.com/
Investor Relations: https://diasoringroup.com/en/investors
Phone: 3901614871
DIASORIN SPA / DIA.MI FAQ
What is the stock price of DIASORIN SPA today?
The current stock price of DIA.MI is 96.42 EUR. The price increased by 1.07% in the last trading session.
What is the ticker symbol for DIASORIN SPA stock?
The exchange symbol of DIASORIN SPA is DIA and it is listed on the Euronext Milan exchange.
On which exchange is DIA.MI stock listed?
DIA.MI stock is listed on the Euronext Milan exchange.
What is the price forecast or stock price prediction for DIASORIN SPA stock?
19 analysts have analysed DIA.MI and the average price target is 110.4 EUR. This implies a price increase of 14.5% is expected in the next year compared to the current price of 96.42. Check the DIASORIN SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is DIASORIN SPA worth?
DIASORIN SPA (DIA.MI) has a market capitalization of 5.39B EUR. This makes DIA.MI a Mid Cap stock.
How many employees does DIASORIN SPA have?
DIASORIN SPA (DIA.MI) currently has 3186 employees.
What are the support and resistance levels for DIASORIN SPA (DIA.MI) stock?
DIASORIN SPA (DIA.MI) has a resistance level at 99.55. Check the full technical report for a detailed analysis of DIA.MI support and resistance levels.
Is DIASORIN SPA (DIA.MI) expected to grow?
The Revenue of DIASORIN SPA (DIA.MI) is expected to grow by 3.71% in the next year. Check the estimates tab for more information on the DIA.MI EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy DIASORIN SPA (DIA.MI) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of DIA.MI, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of DIA.MI, evaluating the profitability, health, valuation and growth aspects
- DIASORIN SPA (DIA.MI) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- DIASORIN SPA (DIA.MI) Sales and EPS estimates to see what analysts future expectations are.
- DIASORIN SPA (DIA.MI) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- DIASORIN SPA (DIA.MI) Insider and Institutional Ownership to learn about the owners and their transactions.
- DIASORIN SPA (DIA.MI) Stock Chart to make your own analysis
- DIASORIN SPA (DIA.MI) Latest news and press-releases to stay up to date.
Does DIASORIN SPA (DIA.MI) stock pay dividends?
DIASORIN SPA (DIA.MI) has a dividend yield of 1.21%. The yearly dividend amount is currently 1.1. Check the full fundamental report for a detailed analysis of DIA.MI dividend history, reliability and sustainability.
When does DIASORIN SPA (DIA.MI) report earnings?
DIASORIN SPA (DIA.MI) will report earnings on 2025-03-14, after the market close.
What is the Price/Earnings (PE) ratio of DIASORIN SPA (DIA.MI)?
The PE ratio for DIASORIN SPA (DIA.MI) is 27.55. This is based on the reported non-GAAP earnings per share of 3.5 and the current share price of 96.42 EUR. Check the full fundamental report for a full analysis of the valuation metrics for DIA.MI.
DIA.MI Technical Analysis
DIA.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to DIA.MI. While DIA.MI has a great health rating, its profitability is only average at the moment.
DIA.MI Financial Highlights
Over the last trailing twelve months DIA.MI reported a non-GAAP Earnings per Share(EPS) of 3.5. The EPS decreased by -33.41% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.92% | ||
| ROA | 5.11% | ||
| ROE | 9.89% | ||
| Debt/Equity | 0.6 |
DIA.MI Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 69% to DIA.MI. The Buy consensus is the average rating of analysts ratings from 19 analysts.
For the next year, analysts expect an EPS growth of 24.78% and a revenue growth 3.71% for DIA.MI